Androgen insensitivity syndrome epidemiology and demographics: Difference between revisions
| Line 26: | Line 26: | ||
===Developed Countries=== | ===Developed Countries=== | ||
*There have been no studies suggesting the difference in the occurrence of AIS in both developed and developing countries. Except for the establishment of two influential support groups, the AIS Support Group (which has branches in the UK, North America and Australia) and the Intersex Society of North America (ISNA). <ref name="pmid9642623">{{cite journal| author=Warne GL, Zajac JD, MacLean HE| title=Androgen insensitivity syndrome in the era of molecular genetics and the Internet: a point of view. | journal=J Pediatr Endocrinol Metab | year= 1998 | volume= 11 | issue= 1 | pages= 3-9 | pmid=9642623 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9642623 }} </ref> | |||
===Developing Countries=== | ===Developing Countries=== | ||
Revision as of 21:36, 11 July 2017
|
Androgen insensitivity syndrome Microchapters |
|
Differentiating Androgen insensitivity syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Androgen insensitivity syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Androgen insensitivity syndrome epidemiology and demographics |
|
FDA on Androgen insensitivity syndrome epidemiology and demographics |
|
CDC on Androgen insensitivity syndrome epidemiology and demographics |
|
Androgen insensitivity syndrome epidemiology and demographics in the news |
|
Blogs on Androgen insensitivity syndrome epidemiology and demographics |
|
Directions to Hospitals Treating Androgen insensitivity syndrome |
|
Risk calculators and risk factors for Androgen insensitivity syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographic
Prevalence
- CAIS has aprevalence of 2 per100,000 to 5 per100,000 in otherwise healthy phenotypic females who had histologically normal inguinal or abdominal testes.
- PAIS is at least as common as CAIS.
- MAIS is much less frequently reported than CAIS and PAIS.
Incidence
- The incidence of complete AIS is about in 5 in 100,000. The incidence of milder degrees of androgen resistance might be both more common or less common than CAIS. Evidence suggests many cases of unexplained male infertility may be due to the mildest forms of androgen resistance.
- In netherlands, the minimal incidence was 1 per 99,000 over a ten-year period.
Case Fatality Rate
Gender
Race
There is no racial predilection for Androgen insensitivity syndrome.
Developed Countries
- There have been no studies suggesting the difference in the occurrence of AIS in both developed and developing countries. Except for the establishment of two influential support groups, the AIS Support Group (which has branches in the UK, North America and Australia) and the Intersex Society of North America (ISNA). [1]
Developing Countries
References
- ↑ Warne GL, Zajac JD, MacLean HE (1998). "Androgen insensitivity syndrome in the era of molecular genetics and the Internet: a point of view". J Pediatr Endocrinol Metab. 11 (1): 3–9. PMID 9642623.